PharmAthene Presents Update on SparVax(TM) rPA Anthrax Vaccine Program at the...
ANNAPOLIS, Md., April 12, 2011 (CRWENewswire)– PharmAthene, Inc. (NYSE Amex: PIP) announced today that Dr. Thomas Fuerst, Executive Vice President and Chief Scientific Officer, presented a...
View ArticleDelaware Chancery Court Issues Final Order And Judgment Upholding Its...
Court Provides Clarity on Payment Process to PharmAthene ANNAPOLIS, Md., June 1, 2012 (CRWENewswire) — PharmAthene, Inc. (NYSE Amex: PIP) today announced that the Delaware Court of Chancery has issued...
View Article
More Pages to Explore .....
